Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Clinical trial NCT06672146 · RECRUITING
Trial details
- NCT number
- NCT06672146
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2027-03-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.